[{"address1": "Chinachem Leighton Plaza", "address2": "9th Floor 29 Leighton Road", "city": "Causeway Bay", "country": "Hong Kong", "phone": "852 2155 0823", "fax": "852 2155 0853", "website": "https://www.regencellbioscience.com", "industry": "Drug Manufacturers - Specialty & Generic", "industryKey": "drug-manufacturers-specialty-generic", "industryDisp": "Drug Manufacturers - Specialty & Generic", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. The company focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder. Regencell Bioscience Holdings Limited was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Yat-Gai  Au", "age": 50, "title": "Founder, Chairman & CEO", "yearBorn": 1973, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Antonia  Assang", "title": "Senior Vice President of Project Management", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Yat-Pui  Au", "age": 49, "title": "Chief Business Officer", "yearBorn": 1974, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "maxAge": 86400, "priceHint": 2, "previousClose": 4.675, "open": 4.9, "dayLow": 4.7501, "dayHigh": 12.5, "regularMarketPreviousClose": 4.675, "regularMarketOpen": 4.9, "regularMarketDayLow": 4.7501, "regularMarketDayHigh": 12.5, "volume": 2726489, "regularMarketVolume": 2726489, "averageVolume": 167690, "averageVolume10days": 291130, "averageDailyVolume10Day": 291130, "marketCap": 79378688, "fiftyTwoWeekLow": 3.03, "fiftyTwoWeekHigh": 32.44, "fiftyDayAverage": 6.13764, "twoHundredDayAverage": 6.03029, "currency": "USD", "enterpriseValue": 71502992, "floatShares": 1462386, "sharesOutstanding": 13012900, "sharesShort": 37382, "sharesShortPriorMonth": 13655, "sharesShortPreviousMonthDate": 1726185600, "dateShortInterest": 1728950400, "heldPercentInsiders": 0.88762003, "heldPercentInstitutions": 0.00057, "shortRatio": 0.36, "impliedSharesOutstanding": 13012900, "bookValue": 0.632, "priceToBook": 9.651898, "lastFiscalYearEnd": 1719705600, "nextFiscalYearEnd": 1751241600, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -4301837, "trailingEps": -0.33, "enterpriseToEbitda": -16.137, "52WeekChange": -0.61712277, "SandP52WeekChange": 0.38860226, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "RGC", "underlyingSymbol": "RGC", "shortName": "Regencell Bioscience Holdings L", "longName": "Regencell Bioscience Holdings Limited", "firstTradeDateEpochUtc": 1626442200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "b7706c4b-f596-300e-bd05-d43d09cde12b", "messageBoardId": "finmb_695870118", "gmtOffSetMilliseconds": -14400000, "currentPrice": 6.1, "recommendationKey": "none", "totalCash": 7961235, "totalCashPerShare": 0.612, "ebitda": -4430946, "totalDebt": 85741, "quickRatio": 41.127, "currentRatio": 41.916, "debtToEquity": 1.043, "returnOnAssets": -0.28114998, "returnOnEquity": -0.43183, "freeCashflow": -2351352, "operatingCashflow": -4001687, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-10-29"}]